discovery of glp 1 Frontiers Science's 2023 Breakthrough: GLP-1R Agonists

Segn la OMS (Organizacin Mundial de la Salud) el 40% de la poblacin mundial est en riesgo de tener un dficit de este mineral

Route of Administration How a peptide is delivered dramatically affects how long it stays in the body: Subcutaneous injection : slower absorption, longer duration Intramuscular injection : faster peak concentration, moderate duration Oral and intranasal peptides : often rapidly broken down, requiring protective technologies or higher doses For example, oral BPC-157 may work primarily through gut-localized pathways, while injectable versions may provide broader systemic benefits

Patients were divided into 3 groups

doi: 10.1002/fsh3.12067